Breaking News

Yesterday
Show Full Stories

X

To view all stories in expanded form, please subscribe.
Send Info
Hot Stocks
J&J pauses vaccinations in all COVID-19 vaccine clinical trials » 18:54
04/13/21
04/13
18:54
04/13/21
18:54
JNJ

Johnson & Johnson

$159.51 /

-2.075 (-1.28%)

In an updated statement,…

In an updated statement, Johnson & Johnson said that it has made the decision to proactively delay the rollout of its COVID-19 vaccine in Europe and pause vaccinations in all Janssen COVID-19 vaccine clinical trials while it updates guidance for investigators and participants. "We have been working closely with medical experts and health authorities, and we strongly support the open communication of this information to healthcare professionals and the public," the company said. Reference Link

ShowHide Related Items >><<
JNJ Johnson & Johnson
$159.51 /

-2.075 (-1.28%)

JNJ Johnson & Johnson
$159.51 /

-2.075 (-1.28%)

04/13/21 Goldman Sachs
J&J vaccine had numerical blood clot imbalance in trial, says Goldman Sachs
04/13/21 Morgan Stanley
Morgan Stanley says J&J news could improve 2022 outlook for mRNA vaccine makers
04/13/21 JPMorgan
Vaccine pause 'incremental negative' for J&J, says JPMorgan
04/13/21 Piper Sandler
Piper reiterates $208 target on Moderna after J&J Covid vaccine pause
JNJ Johnson & Johnson
$159.51 /

-2.075 (-1.28%)

JNJ Johnson & Johnson
$159.51 /

-2.075 (-1.28%)

JNJ Johnson & Johnson
$159.51 /

-2.075 (-1.28%)

JNJ Johnson & Johnson
$159.51 /

-2.075 (-1.28%)

On The Fly
Fly Intel: Wall Street's top stories for Tuesday » 16:27
04/13/21
04/13
16:27
04/13/21
16:27
JNJ

Johnson & Johnson

$159.51 /

-2.075 (-1.28%)

, MRNA

Moderna

$149.63 /

+10.34 (+7.42%)

, COIN

Coinbase

/

+

, AGC

Altimeter Growth

$15.26 /

+1.34 (+9.63%)

, KURI

Alkuri Global Acquisition

$10.01 /

+0.12 (+1.21%)

, BA

Boeing

$253.15 /

+3.49 (+1.40%)

, NVCR

Novocure

$197.33 /

+65.72 (+49.94%)

, AHCO

AdaptHealth

$29.89 /

-7.16 (-19.33%)

, BALY

Bally's

$54.30 /

-6.5 (-10.69%)

, JKPTF

Gamesys Group

$27.00 /

+ (+0.00%)

, ZLAB

Zai Lab

$161.30 /

+29.35 (+22.24%)

The major averages had a…

ShowHide Related Items >><<
ZLAB Zai Lab
$161.30 /

+29.35 (+22.24%)

NVCR Novocure
$197.33 /

+65.72 (+49.94%)

MRNA Moderna
$149.63 /

+10.34 (+7.42%)

JNJ Johnson & Johnson
$159.51 /

-2.075 (-1.28%)

JKPTF Gamesys Group
$27.00 /

+ (+0.00%)

COIN Coinbase
/

+

BALY Bally's
$54.30 /

-6.5 (-10.69%)

BA Boeing
$253.15 /

+3.49 (+1.40%)

AHCO AdaptHealth
$29.89 /

-7.16 (-19.33%)

AGC Altimeter Growth
$15.26 /

+1.34 (+9.63%)

JNJ Johnson & Johnson
$159.51 /

-2.075 (-1.28%)

04/13/21 Goldman Sachs
J&J vaccine had numerical blood clot imbalance in trial, says Goldman Sachs
04/13/21 Morgan Stanley
Morgan Stanley says J&J news could improve 2022 outlook for mRNA vaccine makers
04/13/21 JPMorgan
Vaccine pause 'incremental negative' for J&J, says JPMorgan
04/13/21 Piper Sandler
Piper reiterates $208 target on Moderna after J&J Covid vaccine pause
MRNA Moderna
$149.63 /

+10.34 (+7.42%)

04/07/21 Jefferies
Catalent pact with Moderna removes potential overhang, says Jefferies
03/15/21 Piper Sandler
Piper Sandler bullish on Moderna as first subject vaccinated in '1283 study
COIN Coinbase
/

+

04/13/21
Fly Intel: Top five analyst initiations
04/13/21 MoffettNathanson
Coinbase initiated with a Buy at MoffettNathanson
04/07/21 JMP Securities
Coinbase report shows 'substantial business momentum,' says JMP Securities
03/03/21
Fly Intel: Top five analyst initiations
AGC Altimeter Growth
$15.26 /

+1.34 (+9.63%)

KURI Alkuri Global Acquisition
$10.01 /

+0.12 (+1.21%)

BA Boeing
$253.15 /

+3.49 (+1.40%)

04/09/21 Baird
Baird says add to Boeing on any weakness due to 'tiny fix' needed for MAX jets
03/29/21 Goldman Sachs
Boeing resuming 787 deliveries removes overhang, says Goldman Sachs
03/19/21 Susquehanna
Boeing price target raised to $300 from $250 at Susquehanna
03/15/21 Morgan Stanley
Aerospace sector upgraded to Attractive from Cautious at Morgan Stanley
NVCR Novocure
$197.33 /

+65.72 (+49.94%)

04/13/21 Goldman Sachs
Zai Lab price target raised to $211.23 after LUNAR trial update at Goldman Sachs
04/13/21 Wells Fargo
Novocure price target raised to $215 from $135 at Wells Fargo
04/13/21 Guggenheim
Zai Lab price target raised to $250 from $165 at Guggenheim
04/13/21 Piper Sandler
DMC review 'clear positive' for Novocure, says Piper Sandler
AHCO AdaptHealth
$29.89 /

-7.16 (-19.33%)

04/13/21 RBC Capital
AdaptHealth key leadership remains in place, says RBC Capital
04/13/21 Baird
AdaptHealth downgraded to Neutral from Outperform at Baird
04/13/21 Canaccord
Charges against McGee not related to AdaptHealth, says Canaccord
04/13/21 Stifel
Stifel says AdaptHealth co-CEO news shouldn't have immediate impact on outlook
BALY Bally's
$54.30 /

-6.5 (-10.69%)

04/08/21 KeyBanc
Bally's price target raised to $70 from $65 at KeyBanc
03/29/21 Truist
Early March casino data looks 'very positive,' says Truist
03/25/21 Stifel
Bally's price target raised to $75 from $70 at Stifel
03/24/21 Jefferies
Gamesys Group and Bally's an 'interesting combination,' says Jefferies
JKPTF Gamesys Group
$27.00 /

+ (+0.00%)

03/16/21 Jefferies
Gamesys Group price target raised to 2,150 GBp from 1,930 GBp at Jefferies
03/10/21 Berenberg
Gamesys Group price target raised to 1,700 GBp from 1,550 GBp at Berenberg
03/10/21 Deutsche Bank
Gamesys Group price target raised to 1,580 GBp from 1,510 GBp at Deutsche Bank
ZLAB Zai Lab
$161.30 /

+29.35 (+22.24%)

02/08/21 Jefferies
Zai Lab price target raised to $225 upon assumption at Jefferies
01/15/21 Citi
Citi boosts Zai Lab target to $216, adds to U.S. Focus List
ZLAB Zai Lab
$161.30 /

+29.35 (+22.24%)

NVCR Novocure
$197.33 /

+65.72 (+49.94%)

MRNA Moderna
$149.63 /

+10.34 (+7.42%)

JNJ Johnson & Johnson
$159.51 /

-2.075 (-1.28%)

COIN Coinbase
/

+

BALY Bally's
$54.30 /

-6.5 (-10.69%)

BA Boeing
$253.15 /

+3.49 (+1.40%)

AHCO AdaptHealth
$29.89 /

-7.16 (-19.33%)

  • 14
    Apr
  • 16
    Apr
  • 06
    Jan
  • 15
    Dec
  • 03
    Sep
  • 01
    Jul
  • 19
    May
MRNA Moderna
$149.63 /

+10.34 (+7.42%)

KURI Alkuri Global Acquisition
$10.01 /

+0.12 (+1.21%)

JNJ Johnson & Johnson
$159.51 /

-2.075 (-1.28%)

COIN Coinbase
/

+

BALY Bally's
$54.30 /

-6.5 (-10.69%)

BA Boeing
$253.15 /

+3.49 (+1.40%)

AGC Altimeter Growth
$15.26 /

+1.34 (+9.63%)

MRNA Moderna
$149.63 /

+10.34 (+7.42%)

JNJ Johnson & Johnson
$159.51 /

-2.075 (-1.28%)

JKPTF Gamesys Group
$27.00 /

+ (+0.00%)

COIN Coinbase
/

+

BALY Bally's
$54.30 /

-6.5 (-10.69%)

BA Boeing
$253.15 /

+3.49 (+1.40%)

AGC Altimeter Growth
$15.26 /

+1.34 (+9.63%)

MRNA Moderna
$149.63 /

+10.34 (+7.42%)

JNJ Johnson & Johnson
$159.51 /

-2.075 (-1.28%)

BA Boeing
$253.15 /

+3.49 (+1.40%)

AHCO AdaptHealth
$29.89 /

-7.16 (-19.33%)

AGC Altimeter Growth
$15.26 /

+1.34 (+9.63%)

Upgrade
Amicus upgraded to Overweight from Neutral at Cantor Fitzgerald » 16:11
04/13/21
04/13
16:11
04/13/21
16:11
FOLD

Amicus

$9.29 /

-0.005 (-0.05%)

Cantor Fitzgerald analyst…

Cantor Fitzgerald analyst Kristen Kluska upgraded Amicus to Overweight from Neutral with an unchanged price target of $17.

ShowHide Related Items >><<
FOLD Amicus
$9.29 /

-0.005 (-0.05%)

FOLD Amicus
$9.29 /

-0.005 (-0.05%)

03/01/21 Stifel
Amicus initiated with a Hold at Stifel
02/12/21
Fly Intel: Top five analyst downgrades
02/12/21 JPMorgan
Amicus downgraded to Neutral on Pompe disease miss at JPMorgan
02/12/21 SVB Leerink
Amicus downgraded to Market Perform from Outperform at SVB Leerink
FOLD Amicus
$9.29 /

-0.005 (-0.05%)

FOLD Amicus
$9.29 /

-0.005 (-0.05%)

FOLD Amicus
$9.29 /

-0.005 (-0.05%)

FOLD Amicus
$9.29 /

-0.005 (-0.05%)

Periodicals
South Africa suspends rollout of Johnson & Johnson vaccine, Bloomberg reports » 14:59
04/13/21
04/13
14:59
04/13/21
14:59
JNJ

Johnson & Johnson

$159.16 /

-2.425 (-1.50%)

South Africa has…

South Africa has suspended the rollout of Johnson & Johnson's COVID vaccine after health agencies in the U.S. urged it's suspension, citing concerns about rare and severe blood clotting side effects, Bloomberg's S'thembile Cele and Paul Vecchiatto report. South Africa will suspend its vaccine rollout "until the Johnson & Johnson vaccine is sufficiently interrogated," Health Minister Zweli Mkhize said. Reference Link

ShowHide Related Items >><<
JNJ Johnson & Johnson
$159.16 /

-2.425 (-1.50%)

JNJ Johnson & Johnson
$159.16 /

-2.425 (-1.50%)

04/13/21 Goldman Sachs
J&J vaccine had numerical blood clot imbalance in trial, says Goldman Sachs
04/13/21 Morgan Stanley
Morgan Stanley says J&J news could improve 2022 outlook for mRNA vaccine makers
04/13/21 JPMorgan
Vaccine pause 'incremental negative' for J&J, says JPMorgan
04/13/21 Piper Sandler
Piper reiterates $208 target on Moderna after J&J Covid vaccine pause
JNJ Johnson & Johnson
$159.16 /

-2.425 (-1.50%)

JNJ Johnson & Johnson
$159.16 /

-2.425 (-1.50%)

JNJ Johnson & Johnson
$159.16 /

-2.425 (-1.50%)

JNJ Johnson & Johnson
$159.16 /

-2.425 (-1.50%)

Hot Stocks
FDA grants accelerated approval to Trodelvy for advanced urothelial cancer » 14:40
04/13/21
04/13
14:40
04/13/21
14:40
GILD

Gilead

$64.54 /

-0.09 (-0.14%)

The FDA has granted…

The FDA has granted accelerated approval to sacituzumab govitecan, or Trodelvy, from Immunomedics for patients with unresectable locally advanced or metastatic urothelial cancer, or mUC, who previously received a platinum-containing chemotherapy and either a PD-1 or PD-L1 inhibitor. On October 23, 2020, Gilead Sciences announced the completion of its transaction to acquire Immunomedics.

ShowHide Related Items >><<
GILD Gilead
$64.54 /

-0.09 (-0.14%)

GILD Gilead
$64.54 /

-0.09 (-0.14%)

04/01/21
Fly Intel: Top five analyst upgrades
04/01/21 Bernstein
Gilead upgraded to Outperform from Market Perform at Bernstein
03/30/21 Redburn
Gilead upgraded to Buy from Neutral at Redburn
03/15/21 Mizuho
Merck's Gilead collaboration likely to broaden reach of islatravir, says Mizuho
GILD Gilead
$64.54 /

-0.09 (-0.14%)

GILD Gilead
$64.54 /

-0.09 (-0.14%)

GILD Gilead
$64.54 /

-0.09 (-0.14%)

GILD Gilead
$64.54 /

-0.09 (-0.14%)

On The Fly
Fly Intel: Wall Street's top stories at midday » 12:06
04/13/21
04/13
12:06
04/13/21
12:06
JNJ

Johnson & Johnson

$157.65 /

-3.935 (-2.44%)

, MRNA

Moderna

$149.34 /

+10.05 (+7.22%)

, GRAB

Grab

/

+

, COIN

Coinbase

$0.00 /

+ (+0.00%)

, BA

Boeing

$251.46 /

+1.8 (+0.72%)

, AGC

Altimeter Growth

$13.46 /

-0.46 (-3.30%)

, NVCR

Novocure

$185.99 /

+54.38 (+41.32%)

, CDLX

Cardlytics

$102.70 /

-9.03 (-8.08%)

, AHCO

AdaptHealth

$31.35 /

-5.7 (-15.38%)

, BALY

Bally's

$54.81 /

-5.99 (-9.85%)

, JKPTF

Gamesys Group

$27.00 /

+ (+0.00%)

The major averages are…

ShowHide Related Items >><<
NVCR Novocure
$185.99 /

+54.38 (+41.32%)

MRNA Moderna
$149.34 /

+10.05 (+7.22%)

JNJ Johnson & Johnson
$157.65 /

-3.935 (-2.44%)

JKPTF Gamesys Group
$27.00 /

+ (+0.00%)

COIN Coinbase
$0.00 /

+ (+0.00%)

CDLX Cardlytics
$102.70 /

-9.03 (-8.08%)

BALY Bally's
$54.81 /

-5.99 (-9.85%)

BA Boeing
$251.46 /

+1.8 (+0.72%)

AHCO AdaptHealth
$31.35 /

-5.7 (-15.38%)

AGC Altimeter Growth
$13.46 /

-0.46 (-3.30%)

JNJ Johnson & Johnson
$157.65 /

-3.935 (-2.44%)

04/13/21 Goldman Sachs
J&J vaccine had numerical blood clot imbalance in trial, says Goldman Sachs
04/13/21 Morgan Stanley
Morgan Stanley says J&J news could improve 2022 outlook for mRNA vaccine makers
04/13/21 JPMorgan
Vaccine pause 'incremental negative' for J&J, says JPMorgan
04/13/21 Piper Sandler
Piper reiterates $208 target on Moderna after J&J Covid vaccine pause
MRNA Moderna
$149.34 /

+10.05 (+7.22%)

04/07/21 Jefferies
Catalent pact with Moderna removes potential overhang, says Jefferies
03/15/21 Piper Sandler
Piper Sandler bullish on Moderna as first subject vaccinated in '1283 study
GRAB Grab
/

+

COIN Coinbase
$0.00 /

+ (+0.00%)

04/13/21
Fly Intel: Top five analyst initiations
04/13/21 MoffettNathanson
Coinbase initiated with a Buy at MoffettNathanson
04/07/21 JMP Securities
Coinbase report shows 'substantial business momentum,' says JMP Securities
03/03/21
Fly Intel: Top five analyst initiations
BA Boeing
$251.46 /

+1.8 (+0.72%)

04/09/21 Baird
Baird says add to Boeing on any weakness due to 'tiny fix' needed for MAX jets
03/29/21 Goldman Sachs
Boeing resuming 787 deliveries removes overhang, says Goldman Sachs
03/19/21 Susquehanna
Boeing price target raised to $300 from $250 at Susquehanna
03/15/21 Morgan Stanley
Aerospace sector upgraded to Attractive from Cautious at Morgan Stanley
AGC Altimeter Growth
$13.46 /

-0.46 (-3.30%)

NVCR Novocure
$185.99 /

+54.38 (+41.32%)

04/13/21 Wells Fargo
Novocure price target raised to $215 from $135 at Wells Fargo
04/13/21 Guggenheim
Zai Lab price target raised to $250 from $165 at Guggenheim
04/13/21 Piper Sandler
DMC review 'clear positive' for Novocure, says Piper Sandler
03/01/21 Mizuho
Novocure price target raised to $175 from $150 at Mizuho
CDLX Cardlytics
$102.70 /

-9.03 (-8.08%)

03/16/21 JPMorgan
Cardlytics price target raised to $130 from $110 at JPMorgan
03/05/21 BofA
Cardlytics upgraded to Neutral from Underperform at BofA
03/05/21 BofA
Cardlytics upgraded to Neutral from Underperform at BofA
03/02/21 Truist
Cardlytics price target raised to $150 from $90 at Truist
AHCO AdaptHealth
$31.35 /

-5.7 (-15.38%)

04/13/21 Canaccord
Charges against McGee not related to AdaptHealth, says Canaccord
04/13/21 Stifel
Stifel says AdaptHealth co-CEO news shouldn't have immediate impact on outlook
04/12/21 Baird
AdaptHealth price target raised to $49 from $47 at Baird
03/18/21 Truist
AdaptHealth initiated with a Buy at Truist amid home health market shift
BALY Bally's
$54.81 /

-5.99 (-9.85%)

04/08/21 KeyBanc
Bally's price target raised to $70 from $65 at KeyBanc
03/29/21 Truist
Early March casino data looks 'very positive,' says Truist
03/25/21 Stifel
Bally's price target raised to $75 from $70 at Stifel
03/24/21 Jefferies
Gamesys Group and Bally's an 'interesting combination,' says Jefferies
JKPTF Gamesys Group
$27.00 /

+ (+0.00%)

03/16/21 Jefferies
Gamesys Group price target raised to 2,150 GBp from 1,930 GBp at Jefferies
03/10/21 Berenberg
Gamesys Group price target raised to 1,700 GBp from 1,550 GBp at Berenberg
03/10/21 Deutsche Bank
Gamesys Group price target raised to 1,580 GBp from 1,510 GBp at Deutsche Bank
NVCR Novocure
$185.99 /

+54.38 (+41.32%)

MRNA Moderna
$149.34 /

+10.05 (+7.22%)

JNJ Johnson & Johnson
$157.65 /

-3.935 (-2.44%)

COIN Coinbase
$0.00 /

+ (+0.00%)

CDLX Cardlytics
$102.70 /

-9.03 (-8.08%)

BALY Bally's
$54.81 /

-5.99 (-9.85%)

BA Boeing
$251.46 /

+1.8 (+0.72%)

AHCO AdaptHealth
$31.35 /

-5.7 (-15.38%)

  • 14
    Apr
  • 16
    Apr
  • 03
    Mar
  • 06
    Jan
  • 15
    Dec
  • 03
    Sep
  • 01
    Jul
  • 19
    May
MRNA Moderna
$149.34 /

+10.05 (+7.22%)

JNJ Johnson & Johnson
$157.65 /

-3.935 (-2.44%)

COIN Coinbase
$0.00 /

+ (+0.00%)

BALY Bally's
$54.81 /

-5.99 (-9.85%)

BA Boeing
$251.46 /

+1.8 (+0.72%)

AGC Altimeter Growth
$13.46 /

-0.46 (-3.30%)

MRNA Moderna
$149.34 /

+10.05 (+7.22%)

JNJ Johnson & Johnson
$157.65 /

-3.935 (-2.44%)

JKPTF Gamesys Group
$27.00 /

+ (+0.00%)

COIN Coinbase
$0.00 /

+ (+0.00%)

BALY Bally's
$54.81 /

-5.99 (-9.85%)

BA Boeing
$251.46 /

+1.8 (+0.72%)

AGC Altimeter Growth
$13.46 /

-0.46 (-3.30%)

MRNA Moderna
$149.34 /

+10.05 (+7.22%)

JNJ Johnson & Johnson
$157.65 /

-3.935 (-2.44%)

BA Boeing
$251.46 /

+1.8 (+0.72%)

AHCO AdaptHealth
$31.35 /

-5.7 (-15.38%)

AGC Altimeter Growth
$13.46 /

-0.46 (-3.30%)

On The Fly
Johnson & Johnson under pressure as FDA calls for pause on COVID vaccine » 11:12
04/13/21
04/13
11:12
04/13/21
11:12
JNJ

Johnson & Johnson

$157.42 /

-4.165 (-2.58%)

, MRNA

Moderna

$150.11 /

+10.82 (+7.77%)

, PFE

Pfizer

$37.14 /

+0.16 (+0.43%)

Shares of Johnson &…

ShowHide Related Items >><<
PFE Pfizer
$37.14 /

+0.16 (+0.43%)

MRNA Moderna
$150.11 /

+10.82 (+7.77%)

JNJ Johnson & Johnson
$157.42 /

-4.165 (-2.58%)

JNJ Johnson & Johnson
$157.42 /

-4.165 (-2.58%)

04/13/21 Goldman Sachs
J&J vaccine had numerical blood clot imbalance in trial, says Goldman Sachs
04/13/21 Morgan Stanley
Morgan Stanley says J&J news could improve 2022 outlook for mRNA vaccine makers
04/13/21 JPMorgan
Vaccine pause 'incremental negative' for J&J, says JPMorgan
04/13/21 Piper Sandler
Piper reiterates $208 target on Moderna after J&J Covid vaccine pause
MRNA Moderna
$150.11 /

+10.82 (+7.77%)

04/07/21 Jefferies
Catalent pact with Moderna removes potential overhang, says Jefferies
03/15/21 Piper Sandler
Piper Sandler bullish on Moderna as first subject vaccinated in '1283 study
PFE Pfizer
$37.14 /

+0.16 (+0.43%)

04/09/21
Pfizer to host conference call
04/06/21 RBC Capital
Pfizer transferred with a Sector Perform at RBC Capital
PFE Pfizer
$37.14 /

+0.16 (+0.43%)

MRNA Moderna
$150.11 /

+10.82 (+7.77%)

JNJ Johnson & Johnson
$157.42 /

-4.165 (-2.58%)

  • 19
    May
PFE Pfizer
$37.14 /

+0.16 (+0.43%)

MRNA Moderna
$150.11 /

+10.82 (+7.77%)

JNJ Johnson & Johnson
$157.42 /

-4.165 (-2.58%)

PFE Pfizer
$37.14 /

+0.16 (+0.43%)

MRNA Moderna
$150.11 /

+10.82 (+7.77%)

JNJ Johnson & Johnson
$157.42 /

-4.165 (-2.58%)

PFE Pfizer
$37.14 /

+0.16 (+0.43%)

MRNA Moderna
$150.11 /

+10.82 (+7.77%)

JNJ Johnson & Johnson
$157.42 /

-4.165 (-2.58%)

On The Fly
FedEx, Booking Holdings upgrades among today's top calls on Wall Street » 10:13
04/13/21
04/13
10:13
04/13/21
10:13
FDX

FedEx

$289.91 /

-0.815 (-0.28%)

, BKNG

Booking Holdings

$2,374.18 /

-37.09 (-1.54%)

, JBLU

JetBlue

$19.67 /

-0.825 (-4.03%)

, BMY

Bristol-Myers

$63.41 /

+0.71 (+1.13%)

, KO

Coca-Cola

$53.24 /

-0.13 (-0.24%)

, PEP

PepsiCo

$143.60 /

+0.49 (+0.34%)

, STZ

Constellation Brands

$225.52 /

-0.88 (-0.39%)

, STZ.B

Constellation Brands; also tag STZ

$226.60 /

+ (+0.00%)

, TAP

Molson Coors

$50.95 /

+0.32 (+0.63%)

Check out today's top…

ShowHide Related Items >><<
TAP Molson Coors
$50.95 /

+0.32 (+0.63%)

STZ.B Constellation Brands; also tag STZ
$226.60 /

+ (+0.00%)

STZ Constellation Brands
$225.52 /

-0.88 (-0.39%)

PEP PepsiCo
$143.60 /

+0.49 (+0.34%)

KO Coca-Cola
$53.24 /

-0.13 (-0.24%)

JBLU JetBlue
$19.67 /

-0.825 (-4.03%)

FDX FedEx
$289.91 /

-0.815 (-0.28%)

BMY Bristol-Myers
$63.41 /

+0.71 (+1.13%)

BKNG Booking Holdings
$2,374.18 /

-37.09 (-1.54%)

FDX FedEx
$289.91 /

-0.815 (-0.28%)

04/13/21
Fly Intel: Top five analyst upgrades
04/12/21 KeyBanc
FedEx upgraded to Overweight from Sector Weight at KeyBanc
04/12/21 KeyBanc
FedEx upgraded to Overweight from Sector Weight at KeyBanc
04/08/21 JPMorgan
FedEx added to Analyst Focus List as value idea at JPMorgan
BKNG Booking Holdings
$2,374.18 /

-37.09 (-1.54%)

04/13/21 Jefferies
Booking Holdings upgraded to Buy on coming travel rebound at Jefferies
04/13/21 Jefferies
Booking Holdings upgraded to Buy from Hold at Jefferies
04/05/21 Evercore ISI
Booking Holdings assumed with an In Line at Evercore ISI
JBLU JetBlue
$19.67 /

-0.825 (-4.03%)

04/13/21 Susquehanna
JetBlue upgraded to Positive at Susquehanna
04/13/21 Susquehanna
JetBlue upgraded to Positive from Neutral at Susquehanna
04/06/21 Morgan Stanley
JetBlue price target raised to $30 from $18 at Morgan Stanley
BMY Bristol-Myers
$63.41 /

+0.71 (+1.13%)

04/13/21 Truist
Bristol-Myers upgraded to Buy at Truist on improving pipeline asset visibility
04/13/21 Truist
Bristol-Myers upgraded to Buy from Hold at Truist
04/12/21 B. Riley
B. Riley calls Agenus the next Seagen, reiterates $8 target
03/08/21 BofA
Gartner added to US 1 List, Bristol-Myers removed at BofA
KO Coca-Cola
$53.24 /

-0.13 (-0.24%)

04/12/21 Wolfe Research
Coca-Cola initiated with a Peer Perform at Wolfe Research
03/11/21 Morgan Stanley
Morgan Stanley downgrades Keurig Dr Pepper to Equal Weight after outperformance
03/08/21
Fly Intel: Top five analyst upgrades
03/08/21 RBC Capital
Coca-Cola upgraded to Outperform from Sector Perform at RBC Capital
PEP PepsiCo
$143.60 /

+0.49 (+0.34%)

04/12/21 Wolfe Research
PepsiCo initiated with a Peer Perform at Wolfe Research
03/22/21
Fly Intel: Top five analyst upgrades
03/22/21 Barclays
PepsiCo upgraded to Overweight from Equal Weight at Barclays
STZ Constellation Brands
$225.52 /

-0.88 (-0.39%)

04/12/21 Wolfe Research
Constellation Brands initiated with an Outperform at Wolfe Research
04/09/21 MKM Partners
Constellation Brands price target lowered to $216 from $219 at MKM Partners
04/09/21 Morgan Stanley
Constellation Brands pullback a buying opportunity, says Morgan Stanley
04/05/21 Jefferies
Constellation Brands price target raised to $300 from $276 at Jefferies
STZ.B Constellation Brands; also tag STZ
$226.60 /

+ (+0.00%)

11/17/20 Morgan Stanley
Constellation Brands price target raised to $240 from $203 at Morgan Stanley
07/02/20 HSBC
Constellation Brands price target raised to $170 from $147 at HSBC
06/17/20 JPMorgan
Constellation Brands added to Analyst Focus List at JPMorgan
TAP Molson Coors
$50.95 /

+0.32 (+0.63%)

04/12/21 Wolfe Research
Molson Coors initiated with a Peer Perform at Wolfe Research
03/31/21 Citi
Molson Coors price target raised to $61 from $52 at Citi
03/29/21 JPMorgan
Molson Coors price target raised to $46 from $43 at JPMorgan
03/19/21
Fly Intel: Top five analyst downgrades
TAP Molson Coors
$50.95 /

+0.32 (+0.63%)

STZ Constellation Brands
$225.52 /

-0.88 (-0.39%)

PEP PepsiCo
$143.60 /

+0.49 (+0.34%)

KO Coca-Cola
$53.24 /

-0.13 (-0.24%)

JBLU JetBlue
$19.67 /

-0.825 (-4.03%)

FDX FedEx
$289.91 /

-0.815 (-0.28%)

BMY Bristol-Myers
$63.41 /

+0.71 (+1.13%)

BKNG Booking Holdings
$2,374.18 /

-37.09 (-1.54%)

  • 02
    Dec
STZ Constellation Brands
$225.52 /

-0.88 (-0.39%)

PEP PepsiCo
$143.60 /

+0.49 (+0.34%)

KO Coca-Cola
$53.24 /

-0.13 (-0.24%)

JBLU JetBlue
$19.67 /

-0.825 (-4.03%)

FDX FedEx
$289.91 /

-0.815 (-0.28%)

BMY Bristol-Myers
$63.41 /

+0.71 (+1.13%)

TAP Molson Coors
$50.95 /

+0.32 (+0.63%)

STZ.B Constellation Brands; also tag STZ
$226.60 /

+ (+0.00%)

STZ Constellation Brands
$225.52 /

-0.88 (-0.39%)

PEP PepsiCo
$143.60 /

+0.49 (+0.34%)

KO Coca-Cola
$53.24 /

-0.13 (-0.24%)

JBLU JetBlue
$19.67 /

-0.825 (-4.03%)

FDX FedEx
$289.91 /

-0.815 (-0.28%)

BMY Bristol-Myers
$63.41 /

+0.71 (+1.13%)

BKNG Booking Holdings
$2,374.18 /

-37.09 (-1.54%)

TAP Molson Coors
$50.95 /

+0.32 (+0.63%)

STZ Constellation Brands
$225.52 /

-0.88 (-0.39%)

PEP PepsiCo
$143.60 /

+0.49 (+0.34%)

KO Coca-Cola
$53.24 /

-0.13 (-0.24%)

JBLU JetBlue
$19.67 /

-0.825 (-4.03%)

FDX FedEx
$289.91 /

-0.815 (-0.28%)

BMY Bristol-Myers
$63.41 /

+0.71 (+1.13%)

BKNG Booking Holdings
$2,374.18 /

-37.09 (-1.54%)

Periodicals
NY replacing Tuesday's J&J vaccine appointments with Pfizer, Axios reports » 09:48
04/13/21
04/13
09:48
04/13/21
09:48
JNJ

Johnson & Johnson

$157.60 /

-3.985 (-2.47%)

, PFE

Pfizer

$37.46 /

+0.48 (+1.30%)

New York will replace…

New York will replace Johnson & Johnson's (JNJ) COVID-19 vaccines with the Pfizer (PFE) vaccine for appointments scheduled for Tuesday, New York's health commissioner Howard Zucker said, Orion Rummler of Axios reports. The FDA recommended on Tuesday an immediate pause of the use of Johnson & Johnson's COVID-19 vaccine, citing cases of a rare blood clot disorder that six women developed within two weeks after receiving the shot. Reference Link

ShowHide Related Items >><<
PFE Pfizer
$37.46 /

+0.48 (+1.30%)

JNJ Johnson & Johnson
$157.60 /

-3.985 (-2.47%)

JNJ Johnson & Johnson
$157.60 /

-3.985 (-2.47%)

09:34 Today Goldman Sachs
J&J vaccine had numerical blood clot imbalance in trial, says Goldman Sachs
09:33 Today Morgan Stanley
Morgan Stanley says J&J news could improve 2022 outlook for mRNA vaccine makers
09:21 Today JPMorgan
Vaccine pause 'incremental negative' for J&J, says JPMorgan
08:15 Today Piper Sandler
Piper reiterates $208 target on Moderna after J&J Covid vaccine pause
PFE Pfizer
$37.46 /

+0.48 (+1.30%)

04/09/21
Pfizer to host conference call
04/06/21 RBC Capital
Pfizer transferred with a Sector Perform at RBC Capital
PFE Pfizer
$37.46 /

+0.48 (+1.30%)

JNJ Johnson & Johnson
$157.60 /

-3.985 (-2.47%)

PFE Pfizer
$37.46 /

+0.48 (+1.30%)

JNJ Johnson & Johnson
$157.60 /

-3.985 (-2.47%)

PFE Pfizer
$37.46 /

+0.48 (+1.30%)

JNJ Johnson & Johnson
$157.60 /

-3.985 (-2.47%)

PFE Pfizer
$37.46 /

+0.48 (+1.30%)

JNJ Johnson & Johnson
$157.60 /

-3.985 (-2.47%)

Periodicals
CVS Health tells Bloomberg pausing administration of J&J COVID vaccine » 09:48
04/13/21
04/13
09:48
04/13/21
09:48
CVS

CVS Health

$73.85 /

-0.6 (-0.81%)

, JNJ

Johnson & Johnson

$157.33 /

-4.255 (-2.63%)

A CVS Health (CVS)…

A CVS Health (CVS) spokesperson confirmed in emailed comments to Bloomberg that the company is pausing its administration of the Johnson & Johnson (JNJ) COVID-19 vaccine following advice from the FDA and CDC.

ShowHide Related Items >><<
JNJ Johnson & Johnson
$157.33 /

-4.255 (-2.63%)

CVS CVS Health
$73.85 /

-0.6 (-0.81%)

CVS CVS Health
$73.85 /

-0.6 (-0.81%)

04/08/21 Gordon Haskett
Gordon Haskett highlights Encompass Health's 'interesting' Rhode Island trip
03/17/21 Guggenheim
CVS Health downgraded to Neutral at Guggenheim after 34% rally
03/17/21
Fly Intel: Top five analyst downgrades
03/17/21 Guggenheim
CVS Health downgraded to Neutral from Buy at Guggenheim
JNJ Johnson & Johnson
$157.33 /

-4.255 (-2.63%)

09:34 Today Goldman Sachs
J&J vaccine had numerical blood clot imbalance in trial, says Goldman Sachs
09:33 Today Morgan Stanley
Morgan Stanley says J&J news could improve 2022 outlook for mRNA vaccine makers
09:21 Today JPMorgan
Vaccine pause 'incremental negative' for J&J, says JPMorgan
08:15 Today Piper Sandler
Piper reiterates $208 target on Moderna after J&J Covid vaccine pause
JNJ Johnson & Johnson
$157.33 /

-4.255 (-2.63%)

CVS CVS Health
$73.85 /

-0.6 (-0.81%)

JNJ Johnson & Johnson
$157.33 /

-4.255 (-2.63%)

CVS CVS Health
$73.85 /

-0.6 (-0.81%)

JNJ Johnson & Johnson
$157.33 /

-4.255 (-2.63%)

CVS CVS Health
$73.85 /

-0.6 (-0.81%)

JNJ Johnson & Johnson
$157.33 /

-4.255 (-2.63%)

CVS CVS Health
$73.85 /

-0.6 (-0.81%)

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.